Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Gentamicin in Epidermolysis Bullosa
NCT04644627Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Dec 2020
- Primary completion
- Jan 2022
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of gentamicin in epidermolysis bullosa (EB), sponsored by Oslo University Hospital. Started Dec 2020; status: completed.
02
Drugs
gentamicin
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on NCT04644627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04644627.